M. B. YÜZBAŞIOĞLU And A. E. EŞKAZAN, "Bosutinib - related pleural effusion in patients with chronic myeloid leukemia," EXPERT OPINION ON DRUG SAFETY , vol.20, no.4, pp.379-381, 2021
YÜZBAŞIOĞLU, M. B. And EŞKAZAN, A. E. 2021. Bosutinib - related pleural effusion in patients with chronic myeloid leukemia. EXPERT OPINION ON DRUG SAFETY , vol.20, no.4 , 379-381.
YÜZBAŞIOĞLU, M. B., & EŞKAZAN, A. E., (2021). Bosutinib - related pleural effusion in patients with chronic myeloid leukemia. EXPERT OPINION ON DRUG SAFETY , vol.20, no.4, 379-381.
YÜZBAŞIOĞLU, Mebrure, And Ahmet Emre EŞKAZAN. "Bosutinib - related pleural effusion in patients with chronic myeloid leukemia," EXPERT OPINION ON DRUG SAFETY , vol.20, no.4, 379-381, 2021
YÜZBAŞIOĞLU, Mebrure B. And EŞKAZAN, Ahmet E. . "Bosutinib - related pleural effusion in patients with chronic myeloid leukemia." EXPERT OPINION ON DRUG SAFETY , vol.20, no.4, pp.379-381, 2021
YÜZBAŞIOĞLU, M. B. And EŞKAZAN, A. E. (2021) . "Bosutinib - related pleural effusion in patients with chronic myeloid leukemia." EXPERT OPINION ON DRUG SAFETY , vol.20, no.4, pp.379-381.
@article{article, author={Mebrure Burçak YÜZBAŞIOĞLU And author={Ahmet Emre EŞKAZAN}, title={Bosutinib - related pleural effusion in patients with chronic myeloid leukemia}, journal={EXPERT OPINION ON DRUG SAFETY}, year=2021, pages={379-381} }